Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Yamaguchi

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Journal of Anesthesia|January 6, 2026
RE: Response to the readers' comments on our guidelines: Executive summary of the guidelines for prescribing opioid analgesics for chronic non-cancer pain (third edition) by the Japan Society of Pain CliniciansAkifumi Kanai, Masako Iseki, Hiroki Iida, et al.
Journal of Anesthesia|August 11, 2025
Executive summary of the guideline for prescribing opioid analgesics for chronic non-cancer pain (third edition) by the Japan Society of Pain CliniciansAkifumi Kanai, Masako Iseki, Hiroki Iida, et al.
Haematologica|June 13, 2024
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study GroupKoh Izumiyama, Tasuku Inao, Hideki Goto, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Journal of Anesthesia|January 6, 2026
RE: Response to the readers' comments on our guidelines: Executive summary of the guidelines for prescribing opioid analgesics for chronic non-cancer pain (third edition) by the Japan Society of Pain CliniciansAkifumi Kanai, Masako Iseki, Hiroki Iida, et al.
Journal of Anesthesia|August 11, 2025
Executive summary of the guideline for prescribing opioid analgesics for chronic non-cancer pain (third edition) by the Japan Society of Pain CliniciansAkifumi Kanai, Masako Iseki, Hiroki Iida, et al.
Haematologica|June 13, 2024
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study GroupKoh Izumiyama, Tasuku Inao, Hideki Goto, et al.
Pageof 8